Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,320 | 200,000 | 197,000 | 160,000 | 171,000 |
| Marketable Securities | 278,580 | 44,000 | 167,000 | 322,000 | 294,000 |
| Receivables | 1,011,320 | 859,000 | 718,000 | 590,000 | 739,000 |
| Inventories | 995,320 | 832,000 | 565,000 | 497,000 | 483,000 |
| Other current assets | 20 | 0 | 0 | 0 | 0 |
| TOTAL | $2,477,560 | $1,935,000 | $1,647,000 | $1,569,000 | $1,687,000 |
| Non-Current Assets | |||||
| PPE Net | 2,564,580 | 2,277,000 | 1,619,000 | 1,365,000 | 1,375,000 |
| Investments And Advances | 165,960 | 180,000 | 166,000 | 142,000 | 39,000 |
| Other Non-Current Assets | 33,520 | 34,000 | 2,000 | 4,000 | 13,000 |
| TOTAL | $2,764,060 | $2,491,000 | $1,787,000 | $1,511,000 | $1,427,000 |
| Total Assets | $5,241,640 | $4,426,000 | $3,434,000 | $3,080,000 | $3,114,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 153,610 | 121,000 | 115,000 | 122,000 | 109,000 |
| Accrued Expenses | 97,990 | 0 | 0 | 0 | 54,000 |
| Other current liabilities | 639,160 | 600,000 | 494,000 | 561,000 | 443,000 |
| TOTAL | $1,039,360 | $838,000 | $713,000 | $803,000 | $760,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 114,750 | 116,000 | 103,000 | 119,000 | 136,000 |
| aiOther Non-Current Liabilities | 66,140 | 250,000 | 65,000 | 66,000 | 61,000 |
| TOTAL | $358,130 | $366,000 | $329,000 | $306,000 | $305,000 |
| Total Liabilities | $1,397,500 | $1,204,000 | $1,042,000 | $1,109,000 | $1,065,000 |
| Shareholders' Equity | |||||
| Common Shares | 108,050 | 100,000 | 84,000 | 94,000 | 102,000 |
| Retained earnings | 3,214,420 | 2,677,000 | 1,955,000 | 1,547,000 | 1,576,000 |
| Other shareholders' equity | 135,760 | 85,000 | 48,000 | 9,000 | 25,000 |
| TOTAL | $3,844,130 | $3,222,000 | $2,392,000 | $1,971,000 | $2,049,000 |
| Total Liabilities And Equity | $5,241,630 | $4,426,000 | $3,434,000 | $3,080,000 | $3,114,000 |